Stanza, a cell therapy company, received more than $40 million in round C financing
On September 6, Shanghai stansay Biotechnology Co., Ltd. announced that it had completed a round C financing of more than US $40 million. This round of financing was led by CDH VGC (CDH innovation and Growth Fund), and followed by a number of investment institutions. This round of financing will be used for the R & D of innovative couplecar platform technology, promote the development of cell therapy products for colorectal cancer and other solid tumors, and accelerate the process of clinical trials in the United States and China.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 09:33 PM
· Communication
Kwai 616 Shopping Festival ended, and the epidemic policy helped more than 110000 businesses to resume work and production
In-depth
Dec 11, 2023 08:49 PM
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Jan 03, 2021 10:56 AM
Netease's revenue in the first quarter was 23.56 billion yuan, with an estimated 22.64 billion yuan.
See more
Read next
Insight
In-depth
Insight
In-depth